You searched for "retraction"
Sybill Storz 1937 - 2025
Sybill Storz. Surrounded by her closest family, the internationally-renowned Tuttlingen entrepreneur Sybill Storz passed away peacefully on 28 November 2025 at the age of 88. Her family, all the employees, and the Supervisory Board of the family-owned MedTech company KARL...
Vascular Lesions of the Head and Neck: Diagnosis and Management
The primary authors, all working out of New York, have successfully published this up to date text on vascular lesions of the head and neck. The book provides a review of the pathology, basic science, radiologic features and treatment modalities....Introducing Otinova – A unique formula for Otitis Externa
Otinova Ear Spray is a medical device that treats ear canal inflammation/otitis externa, sometimes known as ‘swimmers ear’.
Platelet-rich plasma-cartilage tympanoplasty
This systematic review and meta-analysis of five studies (n=234 patients) reports the effectiveness of type I tympanoplasty with cartilage and platelet-rich plasma (PRP) compared with type I cartilage tympanoplasty alone for closure of dry tympanic membrane perforations. This is an...Nasal sidewall reconstruction
Expert reconstruction of nasal sidewall defects requires careful selection of techniques across nasal layers, balancing aesthetics, structural support and patient needs. When reconstructing a nasal skin defect, a variety of factors should be taken into account in order to achieve...Royal Society of Medicine – the year ahead
Professor Peter Andrews and Professor Manohar Bance look forward to 2022-23.From the editor March/April 2024
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTW / X: @Voicedoctor_uk Changes are afoot here at ENT & Audiology News, so loyal readers will notice a few differences for March/April...
A single blinded RCT comparing triamcinolone with 5-FU treatment for keloid scars
This single blinded RCT compared 43 patients with 50 symptomatic keloids that were randomised to two matched groups of 25 scars, receiving either 5-fluorouracil (5-FU) or current first line treatment, triamcinolone (TAC). The surgeon administering the injectable treatments was unblinded,...
Bevacizumab, NF2, hearing and age
Introduction NF2-related schwannomatosis (NF2-SWN) is an autosomal dominant disorder leading to the development of schwannomas, meningiomas and spinal cord ependymomas. Younger age is a negative prognostic factor. Treatment includes observation, surgery, radiotherapy and medical therapy with bevacizumab (VEGF monoclonal antibody)....National selection: is the research section of the portfolio fit for purpose?
Applications for ENT training roles in every country require certain criteria to be met. In the UK, ST3 recruitment applications have scores allocated to research experience. In this opinion piece, the authors share their assessment of the potential issues around...
